Zerodha > Trade @ ₹20 (Free Delivery)Know More
Free Account Opening + AMC Free Demat

Curis Lifesciences IPO vs Katex Exim IPO

Comparison between Curis Lifesciences IPO and Katex Exim IPO.

IPO Details

Curis Lifesciences IPO is a SME Fixed Price IPO proposed to list at NSE SME while Katex Exim IPO is a SME Fixed Price proposed to list at BSE SME.

 Curis Lifesciences IPOKatex Exim IPO
LogoCuris Lifesciences IPO LogoKatex Exim IPO Logo
Issue CategorySMESME
Issue TypeIPOIPO
Process TypeBookbuildingFixed Price
Listing AtNSE SMEBSE SME
Lead ManagersSwastika Investmart Ltd.Nirbhay Capital Services Pvt.Ltd.
RegistrarMUFG Intime India Pvt.Ltd.Bigshare Services Pvt.Ltd.
Market Maker
DRHPDRHP DRHP
RHPRHP
Anchor Investor
IPO Allotment URL

Issue Size and Price

The total issue size of Curis Lifesciences IPO is up to ₹0.00 Cr whereas the issue size of the Katex Exim IPO is up to ₹0.00 Cr. The final issue price of Curis Lifesciences IPO is and of Katex Exim IPO is .

 Curis Lifesciences IPOKatex Exim IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final)
Discount (Retail)
Discount (Employee)
Market Lot Size
Fresh Issue Size22,50,000 shares66,00,000 shares
Fresh Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total22,50,000 shares66,00,000 shares
Issue Size Total (Amount)up to ₹0.00 Crup to ₹0.00 Cr

IPO Timetable

Curis Lifesciences IPO opens on , while Katex Exim IPO opens on . The closing date of Curis Lifesciences IPO and Katex Exim IPO is , and , respectively.

 Curis Lifesciences IPOKatex Exim IPO
Anchor Bid Date
Issue Open
Issue Close
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials & KPIs

Curis Lifesciences IPO P/E ratio is , as compared to Katex Exim IPO P/E ratio of .

 Curis Lifesciences IPOKatex Exim IPO
Financials

Curis Lifesciences Limited Financial Information (Restated)

Period Ended31 Dec 202431 Mar 202431 Mar 202331 Mar 2022
Assets50.1233.8229.6727.40
Total Income36.9135.8936.3923.76
Profit After Tax5.305.031.850.49
EBITDA8.898.413.253.58
Net Worth15.535.970.950.90
Reserves and Surplus9.595.470.45-1.40
Total Borrowing16.1617.0916.1917.62
Amount in ₹ Crore

Katex Exim Limited Financial Information (Restated)

Period Ended31 Dec 202331 Mar 202331 Mar 2022
Assets89.5984.0674.53
Total Income137.27123.14142.9
Profit After Tax7.953.712.02
Net Worth25.8515.8712.14
Reserves and Surplus16.376.913.2
Total Borrowing53.2455.3453.43
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)92.68
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap
ROE145.20%26.39%
ROCE34.89%13.67%
Debt/Equity2.863.48
EPS
RoNW84.12%23.37%

Shares Offered

In the Curis Lifesciences IPO Retail Individual Investors (RII) are offered 0 shares while in Katex Exim IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Curis Lifesciences IPO and in Katex Exim IPO.

 Curis Lifesciences IPOKatex Exim IPO
Anchor Investor Reserveration0 shares
Market Maker Reserveration0 shares3,32,000 shares
QIB0 shares
NII0 shares
RII0 shares
Employee0 shares
Others
Total0 shares

Bids Received (Subscription)

Curis Lifesciences IPO subscribed in total, whereas Katex Exim IPO subscribed .

 Curis Lifesciences IPOKatex Exim IPO
QIB (times)
NII (times)
Big NII (times)
Small NII (times)
RII (times)
Employee (times)
Other (times)
Total (times)